Streamlined Laboratory Integration With INTEGRA’s Electronic and Automated Liquid Handling Solutions

Rapid technological advancements in the life sciences field have made automation a key focus for many laboratories, and INTEGRA Biosciences is proud to provide advanced liquid handling solutions to streamline laboratory protocols.

Samsung adds another Lucentis interchangeable biosimilar to the mix

The FDA earlier this month signed off on another interchangeable biosimilar, one of just a handful to date, this time to Samsung Bioepis for its

October 25, 2023

Relief Therapeutics Secures up to $11 Million from Royalty Sales – Biotech Investments

Relief Therapeutics Holding SA / Key word(s): Miscellaneous 05-Aug-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

August 6, 2024

FDA withdraws Helsinn’s accelerated approval for cancer drug after company’s request

The FDA on Friday withdrew an accelerated approval for Helsinn’s bile duct cancer drug, two years after the company couldn’t complete its confirmatory trial and

May 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.